NCT00524641

Brief Summary

To investigate the change in patient's asthma symptom control using ACQ scores after 4 to 6 weeks of Symbicort Turbuhaler (budesonide/ formoterol) in SMART approach.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
1,254

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Jul 2007

Shorter than P25 for all trials

Geographic Reach
1 country

2 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

July 1, 2007

Completed
2 months until next milestone

First Submitted

Initial submission to the registry

August 30, 2007

Completed
4 days until next milestone

First Posted

Study publicly available on registry

September 3, 2007

Completed
6 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 1, 2008

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

April 1, 2008

Completed
Last Updated

July 9, 2009

Status Verified

July 1, 2009

Enrollment Period

8 months

First QC Date

August 30, 2007

Last Update Submit

July 8, 2009

Conditions

Asthma

Keywords

AsthmaSymbicortNIS

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

Hospital out-patient departments and private clinics in all areas of Vietnam

You may qualify if:

  • Asthma patients from both sexes, age 18 or older
  • Have already been on Symbicort SMART treatment
  • Willing to give written informed consents to participate in the program.

You may not qualify if:

  • Patients who are not willing to give written informed consent
  • Patients in emergency care for asthma at ICUs or COPD patients are excluded from the program.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

Research Site

Hanoi, Vietnam

Location

Research Site

Ho Chi Minh City, Vietnam

Location

MeSH Terms

Conditions

Asthma

Condition Hierarchy (Ancestors)

Bronchial DiseasesRespiratory Tract DiseasesLung Diseases, ObstructiveLung DiseasesRespiratory HypersensitivityHypersensitivity, ImmediateHypersensitivityImmune System Diseases

Study Officials

  • Dinh Ngoc SY, MD

    TB and Lung Disease Hospital, Hanoi

    STUDY CHAIR

  • Tran Van Ngoc, MD, PhD

    Cho Ray Hospital

    STUDY CHAIR

  • Nguyen Hong Duc

    Pharm Ngoc Thach Hospital

    STUDY CHAIR

  • Do Van Dung, MD, PhD

    Ho Chi Minh City Univ of Medicine and Pharmacist

    STUDY CHAIR

Study Design

Study Type
observational
Time Perspective
PROSPECTIVE
Sponsor Type
INDUSTRY

Study Record Dates

First Submitted

August 30, 2007

First Posted

September 3, 2007

Study Start

July 1, 2007

Primary Completion

March 1, 2008

Study Completion

April 1, 2008

Last Updated

July 9, 2009

Record last verified: 2009-07

Locations

VN(2)